Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Amortization of Deferred Charges (2021 - 2025)

Historic Amortization of Deferred Charges for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $206000.0.

  • Biote's Amortization of Deferred Charges rose 248.76% to $206000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $832000.0, marking a year-over-year increase of 297.03%. This contributed to the annual value of $819000.0 for FY2024, which is 314.86% up from last year.
  • Biote's Amortization of Deferred Charges amounted to $206000.0 in Q3 2025, which was up 248.76% from $201000.0 recorded in Q2 2025.
  • In the past 5 years, Biote's Amortization of Deferred Charges ranged from a high of $214000.0 in Q4 2024 and a low of $55000.0 during Q3 2021
  • Its 5-year average for Amortization of Deferred Charges is $172411.8, with a median of $201000.0 in 2024.
  • Per our database at Business Quant, Biote's Amortization of Deferred Charges surged by 27090.91% in 2022 and then plummeted by 196.08% in 2023.
  • Biote's Amortization of Deferred Charges (Quarter) stood at $56000.0 in 2021, then surged by 251.79% to $197000.0 in 2022, then increased by 3.05% to $203000.0 in 2023, then grew by 5.42% to $214000.0 in 2024, then dropped by 3.74% to $206000.0 in 2025.
  • Its Amortization of Deferred Charges was $206000.0 in Q3 2025, compared to $201000.0 in Q2 2025 and $211000.0 in Q1 2025.